AstraZeneca admits Covishield vaccine could cause 'rare' blood clots in body, sparks concern
AstraZeneca has acknowledged a potential rare side effect associated with its COVID-19 vaccine, including Covishield, the version widely used in India. This admission, made in legal documents submitted to the UK High Court, has sparked public concern and raised questions about vaccine safety.
